[h5p id=”192″]Recommend0 recommendationsPublished in
Researchers at The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio are recruiting participants for the VIVA-MIND study to learn whether a new drug therapy for Alzheimer’s disease can help people experiencing mild memory problems. Volunteers ages 50 to 89 with a diagnosis of mild cognitive impairment or probable mild …
The post Join the VIVA-MIND Study of an Oral Drug for Alzheimer’s! appeared first on Salud America.